安氟烷市場：按給藥途徑、最終用途分類 - 全球預測 2025-2030

2023年安氟醚市值為2.0639億美元，預計到2024年將達到2.157億美元，複合年成長率為4.59%，預計到2030年將達到2.827億美元。

安氟醚是一種吸入性麻醉劑，主要用於外科手術，並在多項醫療和技術進步的影響下展現出動態的市場概況。儘管安氟烷具有廣泛的適應症，但由於新型、更安全的麻醉劑的出現，其使用已受到一定限制。儘管有這些限制，在特定麻醉劑的成本和需求相容的情況下，安氟烷可能會發揮作用。它因其低成本和低功耗而至關重要，並且在需要快速麻醉起效和恢復的手術室中發揮重要作用。市場促進因素包括全球外科手術數量的增加，特別是在預算限制導致麻醉劑選擇較便宜的新興國家。醫療基礎設施的擴建和手術數量的增加可能會增加對安氟烷市場的需求。然而，SEVOFLURANE和DESFLURANE等新藥的競爭加劇、對環境影響的擔憂以及潛在的副作用等限制因素給廣泛使用帶來了挑戰。儘管如此，輸送機制的創新和改進的配方可能會緩解其中一些挑戰，從而提供一個潛在的研究領域。汽化器技術和精密輸送系統的增強可以減少劑量和副作用，並平衡功效和安全性。此外，透過適當的廢棄物管理來最大限度地減少環境影響的持續研究正在為市場擴張開闢新的途徑。因此，雖然安氟烷市場在成熟地區有些停滯，但對新興市場的策略投資和環保實踐的開拓提供了強勁的成長途徑。由於競爭格局和利基市場，公司必須專注於有針對性的部署並策略性地駕馭監管環境以最佳化成長潛力。

市場動態：揭示快速發展的安氟烷市場的關鍵市場洞察

安氟醚市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

• 市場促進因素
  • 世界各地慢性病和事故的增加
  • 麻醉師越來越喜歡使用安氟烷進行需要短期至中期麻醉的手術
• 市場限制因素
  • 更新、更先進的麻醉劑的出現
• 市場機會
  • 麻醉誘導和監測技術的創新
  • 持續尋找生物分解性且環保的替代品
• 市場問題
  • 安氟烷使用的監管監測和嚴格指南

波特五力：駕馭安氟烷市場的策略工具

波特的五力框架是了解安氟烷市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對安氟醚市場的影響

外部宏觀環境因素在影響安氟醚市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解安氟醚市場的競爭格局

安氟烷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：安氟烷市場供應商績效評估

FPNV定位矩陣是評估安氟醚市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製安氟醚市場的成功之路

安氟烷市場的策略分析對於旨在加強其全球市場影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 全球慢性病和事故的發生率正在增加
    • 安氟烷越來越受到麻醉師用於需要短期至中期麻醉的手術的青睞
  • 抑制因素
    • 新型先進麻醉劑的出現
  • 機會
    • 麻醉管理和監測技術的創新
    • 正在進行生物分解性和環保替代品的研究
  • 任務
    • 安氟烷使用的監管監測和嚴格指南
• 市場區隔分析
  • 給藥途徑：經由吸入增加安氟醚的劑量
  • 最終用途：醫院使用安氟烷方式的演變
• 波特五力分析
• PESTEL分析
  • 政治
  • 經濟
  • 社會
  • 科技
  • 法律
  • 環境

第6章 安氟醚市場：依給藥途徑

• 介紹
• 吸入
• 口服

第7章 安氟醚市場：依最終用途

• 介紹
• 門診手術中心
• 醫院

第8章 美洲安氟烷市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太地區安氟烷市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲安氟烷市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
  • SunMed 完成對 Viair Medical 呼吸和麻醉耗材業務的收購
• 戰略分析和建議

公司名單

• AbbVie Inc.
• Baxter International, Inc.
• Boehringer Ingelheim International GmbH
• Dragerwerk AG & Co. KGaA
• GE HealthCare Technologies Inc.
• Hikma Pharmaceuticals PLC
• J&TEC CO., LTD.
• Sanofi SA

The Enflurane Market was valued at USD 206.39 million in 2023, expected to reach USD 215.70 million in 2024, and is projected to grow at a CAGR of 4.59%, to USD 282.70 million by 2030.

Enflurane, an inhalational anesthetic agent used primarily during surgical procedures, presents a dynamic market profile influenced by several medical and technological advancements. The scope of its application is broad, but its use has been somewhat restricted due to the emergence of newer anesthetics with superior safety profiles. Despite these limitations, enflurane finds relevance in settings where cost considerations and specific anesthetic requirements align. It is essential for its low cost and potency, and serves critical roles in operating rooms where rapid onset and recovery are necessary. The market insights reveal key growth drivers including the rising number of surgeries globally, especially in emerging economies where budget constraints prompt consideration of less expensive anesthetic options. Opportunities lie prominently in expanding healthcare infrastructure and increasing surgical volumes which can boost the enflurane market demand. However, the market grapples with limitations such as heightened competition from newer agents like sevoflurane and desflurane, concerns regarding environmental impact, and potential adverse effects, which pose challenges to its widespread adoption. Despite these, innovations in delivery mechanisms and improved formulations could mitigate some of these challenges, offering potential areas for research. Enhanced vaporizer technologies and precision delivery systems could reduce dosage requirements and side effects, balancing efficacy and safety. Further, ongoing research into minimizing environmental impact through proper waste management practices provides additional pathways for market expansion. Thus, while enflurane's market is somewhat static in mature regions, strategic investments in emerging markets and the development of greener practices present substantial avenues for growth. As the market's nature is competitive yet niche, it is vital for businesses to emphasize targeted developments and to strategically navigate regulatory landscapes to optimize growth potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enflurane Market

The Enflurane Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of chronic diseases and accidents globally
  • Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
• Market Restraints
  • Emergence of newer and advanced anesthetic agents
• Market Opportunities
  • Technological innovations in anesthesia delivery and monitoring techniques
  • Ongoing research into biodegradable, eco-friendly alternatives
• Market Challenges
  • Regulatory scrutiny and stringent guidelines governing the use of enflurane

Porter's Five Forces: A Strategic Tool for Navigating the Enflurane Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enflurane Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enflurane Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enflurane Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enflurane Market

A detailed market share analysis in the Enflurane Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enflurane Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enflurane Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enflurane Market

A strategic analysis of the Enflurane Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Route of Administration, market is studied across Inhalation and Oral.
• Based on End-Use, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of chronic diseases and accidents globally
    • 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
  • 5.1.2. Restraints
    • 5.1.2.1. Emergence of newer and advanced anesthetic agents
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
    • 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
• 5.2. Market Segmentation Analysis
  • 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
  • 5.2.2. End-Use: Evolving usage of enflurane by hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Enflurane Market, by Route of Administration

• 6.1. Introduction
• 6.2. Inhalation
• 6.3. Oral

7. Enflurane Market, by End-Use

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Enflurane Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Enflurane Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Enflurane Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Baxter International, Inc.
• 3. Boehringer Ingelheim International GmbH
• 4. Dragerwerk AG & Co. KGaA
• 5. GE HealthCare Technologies Inc.
• 6. Hikma Pharmaceuticals PLC
• 7. J&TEC CO., LTD.
• 8. Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
• FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENFLURANE MARKET DYNAMICS
• TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023